CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis-Reference-Cited by-同舟云学术

CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis

Published:2018-01-08 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Nagata Hiroshi¹,Ishihara Soichiro²,Kishikawa Junko³,Sonoda Hirofumi¹,Murono Koji¹,Emoto Shigenobu¹,Kaneko Manabu¹,Sasaki Kazuhito¹,Otani Kensuke¹,Nishikawa Takeshi¹,Tanaka Toshiaki¹,Kiyomatsu Tomomichi¹,Hata Keisuke¹,Kawai Kazushige¹,Nozawa Hiroaki¹

Affiliation:

1. Department of Surgical Oncology, The University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan

2. Department of Surgery, International University of Health and Welfare Sanno Hospital, Minato-ku, Tokyo 107-0052, Japan

3. Department of Surgery, Tohto Bunkyo Hospital, Bunkyo-ku, Tokyo 113-0034, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Glycosylation on the Functional Activity of CD133 and the Accuracy of Its Immunodetection;Biology;2024-06-18

2. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer;Genes & Genomics;2024-02-05

3. Clinical Implications and Prognostic Value of Leucine-Rich G Protein-Coupled Receptor 5 Expression as A Cancer Stem Cell Marker in Malignancies: A Systematic Review and Meta-Analysis;CELL J;2024

4. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons;International Journal of Molecular Sciences;2023-12-12

5. CD133 increases oxidative glucose metabolism of HT29 cancer cells by mitochondrial uncoupling and its inhibition enhances reactive oxygen species-inducing therapy;Nuclear Medicine Communications;2022-05-30